{"title": "Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_devices.xml", "value": "Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190218153209.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190218153209.htm", "summary": "Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI (NM-MRI) -- is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_devices.xml", "value": "Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI (NM-MRI) -- is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness."}, "published": "Mon, 18 Feb 2019 15:32:09 EST", "published_parsed": [2019, 2, 18, 20, 32, 9, 0, 49, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190218153209.htm", "guidislink": false}